Roche, ViiV and Horizon most reputable pharmas: patient groups
PatientView’s annual pharma reputation report, as scored by global patient groups, ranked Roche, ViiV Healthcare and Horizon Therapeutics as the…
Can Novartis’ Fabhalta Strengthen Its Nephrology Franchise?
Novartis NVS announced that the FDA has granted traditional approval to Fabhalta (iptacopan) for slowing kidney function decline…
Oligonucleotides Market Research and Competitive Landscape Report 2026 Featuring Novartis, Astellas, Alnylam Pharmaceuticals, Ionis Pharmaceuticals
Company Logo Key opportunities in the oligonucleotide market include advancing therapeutics for rare and diverse diseases like neurodegenerative…